Pharmabiz

IHH Healthcare sets for next phase of growth in India with successful closure of the open offer for Fortis Healthcare and Fortis Malar Hospitals

IHH Healthcare Asia’s largest and leading multinational healthcare provider, announced plans to accelerate expansion, deepen operational efficiencies, and drive innovation across its India hospital ...
Pharmabiz

EMA recommends conditional marketing authorisation for Serum Life Science Europe’s Anktiva to treat non-muscle invasive bladder cancer

EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Anktiva (nogapendekin alfa inbakicept) to treat adults with a type of bladder cancer that affects the ...
Pharmabiz

US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents

US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents: Waltham, Massachuse ...
Pharmabiz

MOC Cancer Care Centre hosts ONCO 3Sixty 2025 bringing together multi-oncology community

MOC Cancer Care Centre hosts ONCO 3Sixty 2025 bringing together multi-oncology community: Our Bureau, Mumbai Monday, December 15, 2025, 17:40 Hrs [IST] MOC Cancer Care & Research ...
Pharmabiz

Greenspace Herbs opens US base as global demand surges for 'Quantum Ayurveda'

Greenspace Herbs, the Bengaluru-based company has opened a full-scale US office in New Jersey. The expansion comes as international supplement brands rush to secure a supply of the company's ...
Pharmabiz

ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor

ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor: Our Bureau, Mumbai Monday, December 15, 2025, 17:10 Hrs [IST] Funded by th ...
Pharmabiz

Biocon Biologics inks settlement and license agreement to commercialize biosimilar aflibercept worldwide

Biocon Biologics inks settlement and license agreement to commercialize biosimilar aflibercept worldwide: Our Bureau, Bengaluru Monday, December 15, 2025, 16:45 Hrs [IST] Biocon B ...
Pharmabiz

Healthium acquires controlling stake in Paramount Surgimed, expands high-precision surgical consumables business

Healthium acquires controlling stake in Paramount Surgimed, expands high-precision surgical consumables business: Our Bureau, Bengaluru Monday, December 15, 2025, 16:10 Hrs [IST] ...
Pharmabiz

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...
Pharmabiz

Akums introduces enhanced gabapentin ER formulation powered by RetenEx Technology for PHN management

Akums introduces enhanced gabapentin ER formulation powered by RetenEx Technology for PHN management: Our Bureau, Chennai Monday, December 15, 2025, 15:45 Hrs [IST] Akums Drugs & ...
Pharmabiz

NIH clinical trial shows expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anaemia patients

NIH clinical trial shows expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anaemia patients: Maryland Monday, December 15, 2025, 15:00 Hrs [IST] A ...
Pharmabiz

University of Western Australia with AMTZ to position Visakhapatnam as a major Indo-Pacific hub for MedTech innovation

University of Western Australia with AMTZ to position Visakhapatnam as a major Indo-Pacific hub for MedTech innovation: Our Bureau, Bengaluru Monday, December 15, 2025, 14:15 Hrs ...